Voyager Acquisition Stockholders Approve VERAXA Biotech Merger

BROOKLYN, NY, March 13, 2026 Voyager Acquisition Corporation (NASDAQ: VACHU, VACH, VACHW) announced that its stockholders have approved the previously disclosed business combination with VERAXA Biotech AG. The approval was granted at a general meeting held on March 12, 2026. Following the closing of this business combination, the combined entity is anticipated to trade on Nasdaq under the new ticker symbol "VRXA."

The business combination faced significant redemptions from Voyager's Class A ordinary shareholders. A total of 25,217,315 Class A shares, representing approximately 99.67% of the total Class A shares outstanding, were submitted for redemption. These shares will be redeemed, resulting in approximately $885,556 remaining in the Company's trust account. Consequently, only 82,685 Class A shares will convert into shares of the combined company, Veraxa Biotech Holding AG.

... Read on — Members only